Kintor Pharmaceutical Limited (KNTPF)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 34.23 Million | - | - | 698 Thousand |
| Cost of Revenue | 42.22 Million | - | - | - | - | 689 Thousand |
| Gross Profit | -42.22 Million | - | 34.23 Million | - | - | 9000.00 |
| Operating Expenses | 1.03 Billion | 968.86 Million | 869.34 Million | 399.73 Million | 229.5 Million | 109.59 Million |
| Selling, General and Administrative Expenses | 96.02 Million | 63.79 Million | 59.69 Million | 85.69 Million | 21.67 Million | 18.51 Million |
| Research and Development Expenses | 938.9 Million | 827.97 Million | 767.93 Million | 328.76 Million | 214.01 Million | 93.19 Million |
| Other Expenses | - | -258 Thousand | 419 Thousand | -5000.00 | -577 Thousand | 9000.00 |
| Cost and Expenses | 1.07 Billion | 968.86 Million | 869.34 Million | 399.73 Million | 229.5 Million | 110.28 Million |
| Operating Income | -1.06 Billion | -944.52 Million | -839.6 Million | -504.85 Million | -228.68 Million | -104.47 Million |
| Interest Expense | - | 8.18 Million | 2.49 Million | 3.37 Million | 1.81 Million | 3.86 Million |
| Income Tax Expense | 8.04 Million | 1.08 Million | -671 Thousand | 73 Thousand | -2.07 Million | -1.06 Million |
| Earnings before Tax | -1.06 Billion | -953.28 Million | -842.09 Million | -508.22 Million | -232.57 Million | -108.48 Million |
| Net Income | -1.06 Billion | -954.36 Million | -842.09 Million | -508.3 Million | -232.57 Million | -108.48 Million |
| Earnings Per Share Basic | -2.47 | -2.53 | -2.36 | -1.64 | -0.63 | -0.29 |
| Earnings Per Share Diluted | -2.47 | -2.53 | -2.36 | -1.64 | -0.63 | -0.29 |
| Weighted Average Shares Outstanding | 429.06 Million | 376.56 Million | 356.39 Million | 309.35 Million | 367.02 Million | 369.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 429.06 Million | 376.56 Million | 356.39 Million | 309.35 Million | 369.38 Million | 369.38 Million |
| Gross Margin | - | - | 1.00 | - | - | 0.01 |
| EBIT Margin | - | - | -24.24 | - | - | -147.71 |
| Profit Margin | - | - | -24.60 | - | - | -155.42 |
| EBITDA | -1.05 Billion | -928.09 Million | -829.09 Million | -501.11 Million | -226.09 Million | -102.17 Million |
| Earnings Before Tax Margin | - | - | -24.53 | - | - | -149.68 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 155.21 | 156.22 | - | - | - | - |
| Cost of Revenue | 77.61 | 78.11 | 7.12 Million | 42.22 Million | 2892.00 | 1.39 Million |
| Gross Profit | 77.61 | 78.11 | -7.12 Million | -42.22 Million | -2892.00 | -1.39 Million |
| Operating Expenses | 4481.11 | 4510.21 | 110.81 Million | 1.03 Billion | 55.5 Thousand | 30.99 Million |
| Selling, General and Administrative Expenses | 2454.66 | 2470.60 | 4.38 Million | - | 2478.22 | 7.95 Million |
| Research and Development Expenses | 2706.06 | 2723.63 | 106.42 Million | - | 53.02 Thousand | 23.03 Million |
| Other Expenses | -679.61 | -684.02 | - | - | 5.96 | - |
| Cost and Expenses | 4558.71 | 4588.32 | 117.94 Million | 1.07 Billion | 58.4 Thousand | 32.38 Million |
| Operating Income | -4558.71 | -4588.32 | -117.94 Million | -1.06 Billion | -58.4 Thousand | -32.38 Million |
| Interest Expense | 728.22 Thousand | - | 503.46 Thousand | - | - | 872.86 Thousand |
| Income Tax Expense | 1.24 | 1.25 | -1.04 Million | 8.04 Million | 515.96 | -73.14 Thousand |
| Earnings before Tax | -4917.51 | -4949.45 | -118.45 Million | -1.06 Billion | -58.63 Thousand | -30.65 Million |
| Net Income | -4918.75 | -4950.70 | -117.38 Million | -1.06 Billion | -58.12 Thousand | -30.6 Million |
| Earnings Per Share Basic | - | -0.01 | -0.27 | - | -0.14 | -0.07 |
| Earnings Per Share Diluted | - | -0.01 | -0.27 | - | -0.14 | -0.07 |
| Weighted Average Shares Outstanding | 430.42 Million | 430.42 Million | 439.39 Million | 429.06 Million | 429.68 Million | 428.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 430.42 Million | 430.42 Million | 439.39 Million | 429.06 Million | 429.68 Million | 428.45 Million |
| Gross Margin | 0.50 | 0.50 | - | - | - | - |
| EBIT Margin | -28.84 | -28.84 | - | - | - | - |
| Profit Margin | -31.69 | -31.69 | - | - | - | - |
| EBITDA | -4476.29 | -4505.37 | -116.65 Million | - | -57.97 Thousand | -30.99 Million |
| Earnings Before Tax Margin | -29.37 | -29.37 | - | - | - | - |
POLA
MGRX
GOCLCORP
INDX
BTML
SIKA